Sign inJoin waitlistJoin the waitlist

David Pfister

Associate Deputy Physician-in-Chief, Strategic Partnerships · New York Presbyterian Hospital

Credentials: · · · ·

History

Strategic Partnerships Division · New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
1989–1991
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1987–1989
Weill Cornell Medical College
1984–1985
Yale-New Haven Hospital
1983–1984
Internal Medicine
University of Pennsylvania Health System
1982–1983
The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania
1978–1982

Research

Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003
Review · Journal of Clinical Oncology · 2004 · First of 12 authors · Corresponding · 1,134 citations
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · First of 37 authors · 1,128 citations

Jatin Shah
76 papers
NL
Nancy Lee
68 papers
ES
Eric Sherman
65 papers · 1 as a fellow
DK
Dennis Kraus
51 papers
AH
Alan Ho
45 papers
MF
Matthew Fury
38 papers
Richard Wong
36 papers
Michael Zelefsky
35 papers · 1 as a resident
LD
Lara Dunn
34 papers · 6 as a fellow
Ashok Shaha
32 papers
SB
Shrujal Baxi
28 papers
SW
Suzanne Wolden
27 papers

Grants

Acupuncture for Shoulder Syndrome After Ca Surgery
National Cancer Institute · R21
Contact PI · $420.5K · Sloan-Kettering Inst Can Research
2003–2006

Clinical trials

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2014–2022
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2014–2021
Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2012–2017
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Principal investigator · Completed · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2009–2018